# Serum Regucalcin Level and Chronic Hepatitis B

> **NCT05435599** · NA · COMPLETED · sponsor: **Konya Meram State Hospital** · enrollment: 120 (actual)

## Conditions studied

- Chronic Hepatitis b
- Liver Fibrosis

## Interventions

- **DIAGNOSTIC_TEST:** Serum regucalcin level

## Key facts

- **NCT ID:** NCT05435599
- **Lead sponsor:** Konya Meram State Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-08-01
- **Primary completion:** 2020-12-31
- **Final completion:** 2021-12-01
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2022-06-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05435599

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05435599, "Serum Regucalcin Level and Chronic Hepatitis B". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05435599. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*